Pluvia vs. Westergaard Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pluvia vs. Westergaard

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JEFF CHAPMAN who wrote ()	9/26/1998 6:53:00 AM
From: Westergaard	Read Replies (1) of 1267

The following item will be published Monday morning at wbn.com announcing a soon to be available institutional analysis: * Premier Laser (PLSAE NASDAQ): In the Final Analysis It's the Big Idea That Counts and the Products Behind It WBN is in the final stages of activating an Institutional Analysis of Premier Laser at WBN-PLSAE. This has been about as rocky a story over the past six months as you'd want to know as will be detailed in the report. The stock continues to be restricted from trading by NASDAQ which is expected to be lifted shortly. In the final analysis it will be the big idea -- the paradigm shift to laser technology in dentistry -- and the products behind that idea that will determine the future of the company and the stock. Wbn.com Daily will announce when the full report is ready for viewing. Meanwhile, a summation: "Premier is a big investment idea driven by a paradigm shift underway in dental technology. It is the leader in the application of lasers to entistry which WBN estimates will become the technology of choice for 10% of U.S. dentists within three years requiring equipment purchases of several hundreds of $millions and for 30% of U.S. dentists within 5 to 7 years. WBN projects the Company will maintain a minimum 60% share of a $200mm market over the next three years, dropping to 30-40% over the succeeding three years as industry sales expand to $500mm+ annually and competition enters the market as is inevitable. "Since 1991 the Company has developed more than 20 lasers encompassing 9 wavelengths. Important innovations are the first laser to replace the dental drill, the first diode laser in dentistry, the first laser for cataract emulsification, the first Erbium:YAG for ablation of skin and the first laser in clinical trials for tissue molding. Lasers are now used by dentists for four classes of procedures: (1) hard tissue (teeth), (2) soft tissue (gums), (3) light-curing of composite material for fillings, and (4) teeth whitening."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next